IVI submitted comments on the Centers for Medicare and Medicaid Services’ (CMS) initial guidance for the implementation of the Medicare Drug Price Negotiation Program (Medicare DPNP). We appreciate the opportunity to provide comment on this important issue.

Read our full comments here.


About IVI
The Innovation and Value Initiative (IVI) is a 501(c)(3) tax-exempt, non-profit research organization dedicated to advancing the science and improving the practice of health technology assessment through development of novel methods and the creation and application of enhanced health technology assessment models to support local decision-making needs in healthcare.

Contact: Smita Sanwardeker
Phone: 267.909.7661
E-Mail: smita.sanwardeker@thevalueinitiative.org